Millions of Australians consume artificial sweeteners daily, believing they offer a healthier alternative to sugar. But is that really true? A recent study from the University of Adelaide is exploring how low-calorie sweeteners impact the body’s glucose regulation systems and whether they might influence the development of diabetes.
These sweeteners are found in a wide range of products—from sodas and yogurts to protein bars and sugar-free snacks—making them a common fixture in modern diets. Despite their popularity, our understanding of how they affect metabolism remains incomplete. The Adelaide research project, funded by the National Health and Medical Research Council, the Medical Research Future Fund, and Diabetes Australia, aims to fill this knowledge gap.
The team is examining five of the most widely used sweeteners—aspartame, stevia, sucralose, saccharin, and acesulfame potassium—to see how they interact with key organs involved in blood sugar management, such as the intestines, pancreas, and kidneys, along with the gut microbiome. Associate Professor Tongzhi Wu from the university explains that understanding how different sweeteners impact glucose levels could lead to safer dietary guidelines and help identify new pathways for preventing and managing diabetes.
“Many people looking to lose weight or control their blood sugar choose low-calorie sweeteners because they believe they’re healthier than sugar,” Wu notes. “But, although these sweeteners were created to replace sugar without adding calories, accumulating evidence suggests they may not be as metabolically neutral as previously thought.”
The study aims to determine how sweeteners affect glucose absorption and excretion, alter gut bacteria, and whether these changes could influence diabetes risk. Researchers are especially interested in whether sweeteners can impact blood glucose regulation through mechanisms independent of calorie consumption, and if some alternatives are safer than others.
Diabetes is the fastest-growing chronic illness worldwide, affecting over 462 million people globally and nearly 1.2 million within Australia. Artificial sweeteners like NutraSweet (aspyrteme), Natvia (stevia), Splenda (sucralose), Sugarine (saccharin), and Equal (acesulfame potassium) form a market worth over $4.3 billion and are projected to grow to nearly $6.2 billion by 2034.
Professor Chris Rayner, another lead researcher at the university, emphasizes that excess body weight is one of the biggest risk factors for type 2 diabetes. “People often view sweeteners as a simple switch for sugar, but the science is more complex than that,” he explains. “While these products can help reduce sugar intake, we still lack a full understanding of their long-term effects on metabolism.”
By comparing these popular sweeteners, the researchers hope to identify whether certain products influence the body differently and to provide solid evidence to inform future dietary advice. The study is expected to conclude by year’s end, with hopes that its findings will support more informed choices and better health outcomes.
Individuals interested in participating in the ‘Sweet n Sour’ study can visit the university’s website for more details.